CHF
|
2
|
Resverlogix Corp.
|
Nov 18, 2019 07:08PM
|
Re: Added more $2.05 warrants.....
|
2
|
Resverlogix Corp.
|
Jun 13, 2019 03:08PM
|
Re: Estimated Glomerular Filtration Rate
|
2
|
Resverlogix Corp.
|
Nov 17, 2019 05:22PM
|
Re: Notice anything different about #11
|
2
|
Zenith Epigenetics
|
Oct 27, 2023 09:03AM
|
Re: Question about Phase 2
|
2
|
Resverlogix Corp.
|
Mar 12, 2019 11:29AM
|
Re: Additional Exempt Distribution
|
2
|
Zenith Epigenetics
|
Dec 04, 2023 07:33AM
|
Re: Price of ROFR for USA
|
2
|
Resverlogix Corp.
|
Feb 04, 2019 07:53AM
|
Re: Third Eye Loan
|
2
|
Resverlogix Corp.
|
May 15, 2019 01:10PM
|
Re: Question on Rosuvastatin versus Astorvastatin
|
2
|
Resverlogix Corp.
|
Sep 07, 2019 10:32AM
|
Financial Statement Q2, 2023 /MD&A
|
2
|
Resverlogix Corp.
|
Aug 12, 2023 08:50AM
|
Re: ZHCLF trades on the OTC
|
2
|
Zenith Epigenetics
|
Jan 20, 2021 07:53AM
|
Re: An inflammatory cytokine signature predicts COVID-19 severity and survival
|
2
|
Resverlogix Corp.
|
Sep 05, 2020 12:47PM
|
Re: Resverlogix Announces Voting Results from the 2024 Meeting of Shareholders and Closing of Debenture Extension
|
2
|
Resverlogix Corp.
|
Aug 01, 2024 10:41AM
|
Re: Upcoming CVOT results
|
2
|
Resverlogix Corp.
|
Apr 12, 2019 11:11AM
|
Re: Received a response....Third Eye Loan Balance-Updated
|
2
|
Resverlogix Corp.
|
Jul 17, 2019 10:05AM
|
JDSTOX on Stockhouse-Top 10 Franchise Drugs
|
2
|
BIOASIS TECHNOLOGIES INC
|
Aug 16, 2019 03:31PM
|
Re: Exposure in Motley Fool....
|
2
|
Resverlogix Corp.
|
Oct 08, 2019 10:20AM
|
Re: Any day now......
|
2
|
Resverlogix Corp.
|
Jun 01, 2021 12:27PM
|
Re: A few thoughts
|
2
|
Resverlogix Corp.
|
Nov 17, 2019 05:49PM
|
Re: Letting them ride ,
|
2
|
Resverlogix Corp.
|
Jan 03, 2024 07:03AM
|